STOCKHOLDERS’ EQUITY |
6 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 7 – STOCKHOLDERS’ EQUITY
Preferred Stock
The Company has 5,000,000 shares of preferred stock authorized, $0.001 par value. As of March 31, 2025 and September 30, 2024, the Company has no preferred stock outstanding.
Common Stock
The Company has 500,000,000 shares of common stock authorized, $0.001 par value. As of March 31, 2025 and September 30, 2024, the Company had 34,276,816 shares of common stock outstanding.
The Company issued no shares of common stock in the six months ended March 31, 2025 and 2024.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|